-
公开(公告)号:US6124355A
公开(公告)日:2000-09-26
申请号:US78192
申请日:1998-05-13
IPC分类号: A61K9/00 , A61K9/20 , A61K31/216 , A61K31/221 , A01N37/44
CPC分类号: A61K9/0004 , A61K31/216 , A61K31/221 , A61K9/2031 , A61K9/2054
摘要: A composition comprising oxybutynin, a dosage form comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
摘要翻译: 公开了包含奥昔布宁的组合物,包含奥昔布宁的剂型和用于奥昔布宁治疗的奥昔布宁的施用方法。
-
公开(公告)号:US06262115B1
公开(公告)日:2001-07-17
申请号:US09280309
申请日:1999-03-29
IPC分类号: A01N3744
CPC分类号: A61K9/209 , A61K9/0004 , A61K9/2031 , A61K9/2054 , A61K31/216 , A61K31/221 , A61K31/24
摘要: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
摘要翻译: 公开了组合物和剂型,其包含单独的奥昔布宁或伴随着另一种用于治疗的药物。 公开了用于单独/或伴随不同药物的奥昔布宁或根据用于单独治疗失禁的治疗程序以及用于其它治疗的奥昔布宁和不同药物施用奥昔布宁的方法。
-
公开(公告)号:US06919092B2
公开(公告)日:2005-07-19
申请号:US09785805
申请日:2001-02-16
IPC分类号: A61K9/00 , A61K9/20 , A61K31/216 , A61K31/221
CPC分类号: A61K9/209 , A61K9/0004 , A61K9/2031 , A61K9/2054 , A61K31/216 , A61K31/221 , A61K31/24
摘要: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
摘要翻译: 公开了组合物和剂型,其包含单独的奥昔布宁或伴随着另一种用于治疗的药物。 公开了用于单独/或伴随不同药物的奥昔布宁或根据用于单独治疗失禁的治疗程序以及用于其它治疗的奥昔布宁和不同药物施用奥昔布宁的方法。
-
公开(公告)号:US5912268A
公开(公告)日:1999-06-15
申请号:US806773
申请日:1997-02-26
IPC分类号: A61K9/00 , A61K9/20 , A61K9/22 , A61K31/216 , A61K31/221 , A01N37/44
CPC分类号: A61K9/0004 , A61K31/216 , A61K31/221 , A61K9/2031 , A61K9/2054
摘要: A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
摘要翻译: 公开了包含奥昔布宁的组合物,包含奥昔布宁的装置和用于奥昔布宁治疗的给予奥昔布宁的方法。
-
公开(公告)号:US5674895A
公开(公告)日:1997-10-07
申请号:US445849
申请日:1995-05-22
IPC分类号: A61K9/24 , A61K9/00 , A61K9/20 , A61K31/215 , A61K31/216 , A61K31/221 , A61K47/38 , A61P13/02 , A61P15/00 , A01N37/44 , A61K31/24
CPC分类号: A61K9/2054 , A61K31/216 , A61K31/221 , A61K9/0004 , A61K9/2031
摘要: A composition comprising oxybutynin and a device comprising oxybutynin are disclosed for oxybutynin therapy.
摘要翻译: 公开了包含奥昔布宁的组合物和包含奥昔布宁的装置,用于奥昔布宁治疗。
-
公开(公告)号:US5840754A
公开(公告)日:1998-11-24
申请号:US706576
申请日:1996-09-05
IPC分类号: A61K9/24 , A61K9/00 , A61K9/20 , A61K31/215 , A61K31/216 , A61K31/221 , A61K47/38 , A61P13/02 , A61P15/00 , A01N37/44
CPC分类号: A61K9/2054 , A61K31/216 , A61K31/221 , A61K9/0004 , A61K9/2031
摘要: A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
摘要翻译: 公开了包含奥昔布宁的组合物,包含奥昔布宁的装置和用于奥昔布宁治疗的给予奥昔布宁的方法。
-
7.
公开(公告)号:US06548083B1
公开(公告)日:2003-04-15
申请号:US09615110
申请日:2000-07-13
申请人: Patrick S.-L. Wong , Liang-Chang Dong , David E. Edgren , Felix Theeuwes , Phyllis I. Gardner , Francisco Jao , Jason J. Wan
发明人: Patrick S.-L. Wong , Liang-Chang Dong , David E. Edgren , Felix Theeuwes , Phyllis I. Gardner , Francisco Jao , Jason J. Wan
IPC分类号: A61K922
CPC分类号: A61K9/0065 , A61K9/2072
摘要: The present invention is directed to an active agent dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent formulation to a fluid environment of use. The active agent dosage form is a polymer matrix that swells upon contact with the fluids of the stomach. A portion of the polymer matrix is surrounded by a band of insoluble material that prevents the covered portion of the polymer matrix from swelling and provides a segment of the dosage form that is of sufficient rigidity to withstand the contractions of the stomach and delay expulsion of the dosage form from the stomach until substantially all of the active agent has been dispensed.
摘要翻译: 本发明涉及一种活性剂剂型,其适于保留在胃中并且可用于将活性剂制剂延长递送至使用的流体环境。 活性剂剂型是与胃液接触时膨胀的聚合物基质。 聚合物基质的一部分由不溶性材料带包围,其阻止聚合物基质的被覆盖部分膨胀,并提供具有足够刚性以抵抗胃收缩和延迟排出的部分的剂型 剂型,直到基本上所有的活性剂已被分配。
-
公开(公告)号:US6120803A
公开(公告)日:2000-09-19
申请号:US131923
申请日:1998-08-10
申请人: Patrick S. L. Wong , Liang-Chang Dong , David E. Edgren , Felix Theeuwes , Phyllis I. Gardner , Francisco Jao , Jason J. Wan
发明人: Patrick S. L. Wong , Liang-Chang Dong , David E. Edgren , Felix Theeuwes , Phyllis I. Gardner , Francisco Jao , Jason J. Wan
IPC分类号: A61K47/22 , A61K9/00 , A61K9/20 , A61K9/22 , A61K9/26 , A61K31/341 , A61K31/522 , A61K45/00 , A61P31/12
CPC分类号: A61K9/0065 , A61K9/2072
摘要: The present invention is directed to an active agent dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent formulation to a fluid environment of use. The active agent dosage form is a polymer matrix that swells upon contact with the fluids of the stomach. A portion of the polymer matrix is surrounded by a band of insoluble material that prevents the covered portion of the polymer matrix from swelling and provides a segment of the dosage form that is of sufficient rigidity to withstand the contractions of the stomach and delay expulsion of the dosage form from the stomach until substantially all of the active agent has been dispensed.
-
公开(公告)号:US20080021102A1
公开(公告)日:2008-01-24
申请号:US11828028
申请日:2007-07-25
申请人: George Guittard , Francisco Jao , Susan Marks , David Kidney , Fernando Gumucio , Suneel Gupta , Gayatri Sathyan
发明人: George Guittard , Francisco Jao , Susan Marks , David Kidney , Fernando Gumucio , Suneel Gupta , Gayatri Sathyan
CPC分类号: A61K9/209 , A61K9/0004 , A61K9/2031 , A61K9/2054 , A61K31/216 , A61K31/221 , A61K31/24
摘要: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
摘要翻译: 公开了组合物和剂型,其包含单独的奥昔布宁或伴随着另一种用于治疗的药物。 公开了用于单独/或伴随不同药物的奥昔布宁或根据用于单独治疗失禁的治疗程序以及用于其它治疗的奥昔布宁和不同药物施用奥昔布宁的方法。
-
公开(公告)号:US20050019409A1
公开(公告)日:2005-01-27
申请号:US10914486
申请日:2004-08-09
申请人: David Edgren , Francisco Jao , Patrick Wong
发明人: David Edgren , Francisco Jao , Patrick Wong
CPC分类号: A61K9/0065 , Y10S424/06 , Y10S514/836 , Y10S514/866 , Y10S514/884 , Y10S514/909 , Y10S514/96 , Y10S514/961 , Y10S514/965
摘要: The present invention is directed to a multilayered dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent to a fluid environment of use. The active agent dosage form is a multilayer core, often bilayer, formed of polymer matrices that swell upon contact with the fluids of the stomach. At least one layer of the multilayered dosage form includes an active agent. A portion of the polymer matrices are surrounded by a band of insoluble material that prevents the covered portion of the polymer matrices from swelling and provides a segment of the dosage form that is of sufficient rigidity to withstand the contractions of the stomach and delay expulsion of the dosage form from the stomach until substantially all of the active agent has been dispensed.
摘要翻译: 本发明涉及一种多层剂型,其适于保留在胃中并且可用于将活性剂延长递送至使用的流体环境。 活性剂剂型是由与胃液接触时膨胀的聚合物基质形成的多层芯,通常是双层的。 至少一层多层剂型包括活性剂。 聚合物基质的一部分被不溶性材料带包围,其阻止聚合物基质的被覆盖部分膨胀,并且提供具有足够刚度以抵抗胃收缩和延迟排出 剂型,直到基本上所有的活性剂已被分配。
-
-
-
-
-
-
-
-
-